Ceftazidime (WG Critical Care, LLC)
Welcome to the PulseAid listing for the Ceftazidime drug offered from WG Critical Care, LLC. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | WG Critical Care, LLC |
NON-PROPRIETARY NAME: | Ceftazidime |
SUBSTANCE NAME: | CEFTAZIDIME |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-26 |
END MARKETING DATE: | 0000-00-00 |
Ceftazidime HUMAN PRESCRIPTION DRUG Details:
Item Description | Ceftazidime from WG Critical Care, LLC |
LABELER NAME: | WG Critical Care, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/20mL) |
START MARKETING DATE: | 2017-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44567-235_e03f50e0-7798-4d9e-a07a-8282c6125c5b |
PRODUCT NDC: | 44567-235 |
APPLICATION NUMBER: | ANDA062640 |
Other CEFTAZIDIME Pharmaceutical Manufacturers / Labelers: